July 31 (Reuters) - Geneuro Sa GNRO.PA :
* Q2 OPERATING REVENUES OF EUR 1.5 MILLION, COMPARED TO EUR
2.5 MILLION IN SAME PERIOD IN 2016
* CASH POSITION OF EUR 23.5 MILLION AS OF 30 JUNE 2017
* TIMELINE ACCELERATED TO SEPTEMBER FOR TOP-LINE RESULTS OF
PHASE IIB STUDY IN MULTIPLE SCLEROSIS
* CHANGE-MS STUDY: GENEURO NOW EXPECTS TO PRESENT ITS FIRST
TRIAL RESULTS IN SEPTEMBER 2017 RATHER THAN IN EARLY Q4 2017 AS
PREVIOUSLY INDICATED
* Q2 CASH AND CASH EQUIVALENTS TOTALLED EUR 23.5 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nBw4ZMPbza
Further company coverage: GNRO.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))